A pilot clinical trial to evaluate the biological activity of fulvestrant (Faslodex) in breast ductal carcinoma (DCIS)

Trial Profile

A pilot clinical trial to evaluate the biological activity of fulvestrant (Faslodex) in breast ductal carcinoma (DCIS)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2006

At a glance

  • Drugs Fulvestrant; Tamoxifen
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Aug 2006 Status change
    • 09 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top